|
|
|
|
BSM Technologies and Datacom Wireless Announce Letter Agreement for a Business Combination to Create a Major P
BSM Technologies Inc.('BSM')(TSX VENTURE: GPS) and Datacom Wireless Corporation ('Datacom') (TSX VENTURE: DAT) are pleased to announce that they have entered into a binding Letter Agreement dated July 2nd, 2009 (the 'Letter ...
|
|
|
Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, and Pfizer Inc.(NYSE: PFE) have entered into an Acquisition and License Agreement by which Graceway will acquire the worldwide commercial rights for...
|
|
|
Biogen Idec, Acorda Sign Collaboration Agreement For Fampridine-SR
Acorda to continue developing and commercializing Fampridine-SR in the US Biogen Idec and Acorda have signed an exclusive collaboration and license agreement to develop and commercialize Fampridine-SR, a multiple sclerosis (MS) therapy...
|
|
|
Graceway acquires worldwide rights for three dermatological molecules from Pfizer
Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, and Pfizer Inc.announced that they have entered into an acquisition and license agreement by which Graceway will acquire the worldwide commercial rights...
|
|
|
Biogen Idec, Acorda enter pact to develop & commercialize MS therapy Fampridine-SR in outside US markets
Biogen Idec and Acorda Therapeutics, Inc.announced that they have entered into an exclusive collaboration and license agreement to develop and commercialize Fampridine-SR, a multiple sclerosis (MS) therapy, in markets outside the...
|
|
|
Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
(CDI) and Roche announced today a significant expansion of their existing agreement to test drug development candidates for their potential to cause cardiotoxicity, or damage to heart tissue.The two-year collaboration aims to...
|
|
|
Georgia Gulf Announces Amended Private Debt Exchange Offers and Noteholder Lock-Up and Consent Agreements
- Georgia Gulf Corporation (NYSE:GGC) (the Company) today announced it is amending its private exchange offers for its outstanding 7.125 percentSenior Notes due 2013 (the 2013 notes), 9.5 percent Senior Notes due 2014 (the 2014 notes), and...
|
|
|
Outlook Signs Binding Agreement With ERTH Solutions, Inc
Outlook Resources Inc.('Outlook' or the 'Company') (TSX VENTURE: OLR) is pleased to announce that, further to its Press Release dated May 20, 2009, it has signed a binding agreement with ERTH Solutions, Inc. ('ERTH Solutions') to...
|
|
|
Supplements to State Mental Health Data Infrastructure Grants for Quality Improvement
Center for Mental Health Services (CMHS) Request for Applications (RFA) (Initial Announcement) Request for Applications (RFA) No.SM-09-018 Posting on Grants.gov: March 25, 2009 Original Receipt date: May 2, 2009 Revised Receipt date: May...
|
|
|
Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
3582 live jobs on PharmiWeb.com now NEW YORK(BUSINESS WIRE)Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, and Pfizer Inc.(NYSE: PFE) today announced that they have entered into an Acquisition and License ...
|
|
|
Graceway Pharmaceuticals Acquires Early-Stage Dermatological Molecules From Pfizer
Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, and Pfizer Inc.(NYSE:PFE) today announced that they have entered into an Acquisition and License Agreement by which Graceway will acquire the worldwide...
|
|
|
Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
- Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, and Pfizer Inc.(NYSE: PFE) today announced that they have entered into an Acquisition and License Agreement by which Graceway will acquire the...
|
|
|
Unilife signs industrialization agreement with Sanofi-Aventis
(Datamonitor via COMTEX) -- UNIFF | Quote | Chart | News | PowerRating -- Unilife Medical Solutions, a developer of safety syringe technology, has entered into an industrialization agreement with Sanofi Winthrop Industrie, a wholly...
|
|
|
Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy F
Acorda to Continue to Develop and Commercialize Fampridine-SR in the U.S.Upfront Payment of $110 Million; Potential Deal Value Over $500 Million Acorda to Host Conference Call at 8:30 a.m. Eastern Time Today CAMBRIDGE, Ma. &...
|
|
|
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment WEBWIRE Thursday, July 02, 2009 First-in-Class Alzheimer's Treatments Expand Existing J&J...
|
|
|
Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
News source: Business Wire Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, and Pfizer Inc.(NYSE:> We are excited about the potential that these molecules present. Their acquisition is evidence of...
|
|
|
Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, and Pfizer Inc.(NYSE:> We are excited about the potential that these molecules present. Their acquisition is evidence of Graceways ongoing commitment to...
|
|
|
ELAN CORPORATION PLC - Johnson & Johnson, Elan Announce Definitive Agreement
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment First-in-Class Alzheimer's Treatments Expand Existing J&J Neuroscience Pipeline...
|
|
|
Cogitore Resources Signs New Agreement With Inmet Mining
Cogitore Resources Inc.(TSX VENTURE: WOO) ('Cogitore' or the 'Company') announces that it has signed an agreement with Inmet Mining Corporation ('Inmet'), whereby Inmet will immediately transfer to Cogitore all of its interest in...
|
|
|
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program
% Enter Symbols: Sponsored by: and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment First-in-Class Alzheimer's Treatments Expand Existing J&J Neuroscience Pipeline...
|
|
|
ELAN CORPORATION PLC - Johnson & Johnson, Elan Announce Definitive Agreement
(PR Newswire Europe via COMTEX) -- JNJ | Quote | Chart | News | PowerRating -- e>Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment First...
|
|
|
Biogen Idec teams with Acorda Therapeutics on MS therapies
Tagged: Biogen Idec Business Health Health care Medicine Pharmaceutical industry Pharmaceuticals Biogen Idec and Acorda Therapeutics announce collaboration agreement to develop and commercialize MS therapy Fampridine-SR in markets...
|
|
|
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment First-in-Class Alzheimer's Treatments Expand Existing J&J Neuroscience Pipeline NEW BRUNSWICK,...
|
|
|
REG-Elan Corporation PLC: Johnson & Johnson, Elan Announce Definitive Agreement
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment First-in-Class Alzheimer's Treatments Expand Existing J&J Neuroscience Pipeline Johnson &...
|
|
|
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program
and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Invest First-in-Class Alzheimer's Treatments Expand Existing J&J Neuroscience Pipeline Equity Investment Provides Financial...
|
